Redmile Group, LLC
- SEC CIK
- 0001425738
- Latest filing
- Aug 14, 2026
STLN holding history
Starling Oncology, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STLN overviewAll 13F holders of STLNFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −318,082−100.0% | Sold out | Holders |
| Q1 2023 | 318,082 | $215.6K | <0.1% | −1,265,076−79.9% | Reduced | Holders |
| Q4 2022 | 1,583,158 | $2.61M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,583,158 | $7.33M | 0.3% | −152,958−8.8% | Reduced | Holders |
| Q2 2022 | 1,736,116 | $8.79M | 0.3% | −678,316−28.1% | Reduced | Holders |
| Q1 2022 | 2,414,432 | $17.2M | 0.5% | −85,568−3.4% | Reduced | Holders |
| Q4 2021 | 2,500,000 | $24.4M | 0.6% | +2,500,000 | New | Holders |